Refractory Hypoglycemia from Paraneoplastic Insulin-Like growth Factor 2 Secretion in A Patient with Hepatocellular Carcinoma

Refractory Hypoglycemia from Paraneoplastic Insulin-Like growth Factor 2 Secretion in A Patient with Hepatocellular Carcinoma

ABSTRACT: Objective: Hypoglycemia due to insulin-like growth factor (IGF)-2 secretion by a tumor, referred to as non–islet cell tumor hypoglycemia, or IGF-2-oma, is a rare and serious paraneoplastic complication of malignancy. When surgical resection is not an option, studies have shown improvement...

Full description

Bibliographic Details
Main Authors: Stephanie Behringer-Massera, MD, Erika F. Brutsaert, MD, Eric J. Epstein, MD
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060520304351

Internet

http://www.sciencedirect.com/science/article/pii/S2376060520304351

Similar Items